Application 207602
- Type
- ANDA
- Sponsor
- PERRIGO R AND D
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | TABLET, EXTENDED RELEASE;ORAL | 60MG;1.2GM | No | No |
| 002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | TABLET, EXTENDED RELEASE;ORAL | 30MG;600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | ||
| A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5d02ea3f76ae… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Meijer Distribution Inc | cb2b9828-1665-4b66-a59a-b9f9539b51b5 | 2026-09-24 | Warnings | 207602 ANDA207602 41250-812 |
| mucus relief dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Walgreen Company | ba200f15-56dd-4b4d-9f3f-1340f3cb73a5 | 2026-09-24 | Warnings | 207602 ANDA207602 0363-6812 |
| Topcare Mucus DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Topco Associates LLC | 60108084-4be9-4e8a-b354-9438e1694ebc | 2026-09-24 | Warnings | 207602 ANDA207602 36800-592 |
| good sense mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | L Perrigo Company | 654dc991-1984-43cc-a00e-0c85d910b323 | 2026-09-24 | Warnings | 207602 ANDA207602 0113-0812 |
| members mark mucus relief dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Sam's West Inc | 3db5409d-d772-4bf1-a183-37fbe01d53d6 | 2026-09-23 | Warnings | 207602 ANDA207602 |
| Berkley and Jensen Mucus Relief DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | BJWC | d3b94cce-e6f3-43ec-a927-7b7183744433 | 2026-09-23 | Warnings | 207602 ANDA207602 68391-812 |
| Topcare Mucus DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Topco Associates LLC | c12c68c3-c1bf-45dd-a311-fe1005189ec1 | 2026-09-18 | Warnings | 207602 ANDA207602 36800-219 |
| MUCUS DM MAX | DEXTROMETHORPHAN HBR, GUAIFENESIN | Amazon.com Services LLC | 1fd35629-ad48-4a73-b920-ab4428b780c0 | 2026-09-18 | Warnings | 207602 ANDA207602 |
| equate mucus relief dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | WALMART INC. | 1ceed839-93d0-4124-9fb8-63fbb97b75ac | 2026-09-17 | Warnings | 207602 ANDA207602 79903-065 |
| mucus relief dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Meijer Distribution Inc | d41749b4-735b-44f7-ab06-244f68e031e3 | 2026-09-17 | Warnings | 207602 ANDA207602 41250-436 |
| kirkland signature mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Costco Wholesale Company | d2151492-c6bb-42c7-887f-37ef3eab3460 | 2026-09-10 | Warnings | 207602 ANDA207602 |
| Leader Mucus Relief DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Cardinal Health 110, LLC. dba Leader | 7c54d128-9da7-49d7-bda4-9d4f7b8bc652 | 2026-09-01 | Warnings | 207602 ANDA207602 |
| Mucus Relief DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Walgreen Company | d8a693f7-03c1-4583-89a8-8d506a894b24 | 2026-08-28 | Warnings | 207602 ANDA207602 |
| mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | HyVee Inc | 6bce66d6-e76a-4273-aff9-7ee6adc18980 | 2026-08-25 | Warnings | 207602 ANDA207602 |
| good neighbor pharmacy mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Amerisource Bergen | f7925a6b-7029-4389-bf1b-8c0f5e79b950 | 2026-08-25 | Warnings | 207602 ANDA207602 46122-637 |
| DG health mucus dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Dolgencorp Inc | a95401cc-349e-435a-b953-4d8fd1f54744 | 2026-08-24 | Warnings | 207602 ANDA207602 |
| GOOD NEIGHBOR PHARMACY MUCUS DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Amerisource Bergen | f0aea945-1c18-4c6f-a7d1-6d56624011bb | 2026-08-24 | Warnings | 207602 ANDA207602 |
| Rugby Mucus Relief DM ER | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rugby Laboratories | f2629794-4845-4ca6-8668-a21a56f182cb | 2026-07-30 | Warnings | 207602 ANDA207602 |
| up and up mucus relief dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Target Corporation | 9cb3719b-44bc-4ad1-a9c5-e6cc047f4d0e | 2026-07-30 | Warnings | 207602 ANDA207602 11673-716 |
| RUGBY MUCUS RELIEF DM ER | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rugby Laboratories | 8090d561-0478-435d-ad6f-2334e1823bc3 | 2026-07-28 | Warnings | 207602 ANDA207602 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0031-8765 | Robitussin Maximum Strength 12 Hour Cough and Mucus Relief | Dextromethorphan Hydrobromide, Guaifenesin | Wyeth Consumer Healthcare LLC | ANDA | Current |
| 0031-8765 | Robitussin Maximum Strength 12 Hour Cough and Mucus Relief | Dextromethorphan Hydrobromide, Guaifenesin | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | ANDA | Current |
| 0113-0812 | good sense mucus dm | dextromethorphan HBr, guaifenesin | L Perrigo Company | ANDA | Current |
| 0113-0812 | good sense mucus dm | dextromethorphan HBr, guaifenesin | L Perrigo Company | ANDA | Current |
| 0113-2219 | Good Sense Mucus DM | dextromethorphan hydrobromide, guaifenesin | L. Perrigo Company | ANDA | Current |
| 0113-2219 | Good Sense Mucus DM | dextromethorphan hydrobromide, guaifenesin | L. Perrigo Company | ANDA | Current |
| 0113-7419 | basic care mucus dm | dextromethorphan hydrobromide, guaifenesin | L. Perrigo Company | ANDA | Current |
| 0113-7812 | basic care mucus dm | dextromethorphan HBr, guaifenesin | L. Perrigo Company | ANDA | Current |
| 0113-7812 | basic care mucus dm | dextromethorphan HBr, guaifenesin | L. Perrigo Company | ANDA | Current |
| 0280-1660 | Alka-Seltzer Plus Maximum Strength Cough and Mucus DM | Dextromethorphan Hydrobromide, Guaifenesin | Bayer HealthCare LLC. | ANDA | Current |
| 0280-1660 | Alka-Seltzer Plus Maximum Strength Cough and Mucus DM | Dextromethorphan Hydrobromide, Guaifenesin | Bayer HealthCare LLC. | ANDA | Current |
| 0280-1660 | Alka-Seltzer Plus Maximum Strength Cough and Mucus DM | Dextromethorphan Hydrobromide, Guaifenesin | Bayer HealthCare LLC. | ANDA | Current |
| 0363-6812 | mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Walgreen Company | ANDA | Current |
| 0536-1199 | rugby mucus relief dm | dextromethorphan HBr, guaifenesin | Rugby Laboratories | ANDA | Current |
| 11673-235 | up and up maximum strength mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Target Corporation | ANDA | Current |
| 11673-235 | up and up maximum strength mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Target Corporation | ANDA | Current |
| 11673-716 | up and up mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Target Corporation | ANDA | Current |
| 11673-716 | up and up mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Target Corporation | ANDA | Current |
| 36800-219 | Topcare Mucus DM | dextromethorphan hydrobromide, guaifenesin | Topco Associates LLC | ANDA | Current |
| 36800-219 | Topcare Mucus DM | dextromethorphan hydrobromide, guaifenesin | Topco Associates LLC | ANDA | Current |
| 36800-592 | Topcare Mucus DM | dextromethorphan HBr, guaifenesin | Topco Associates LLC | ANDA | Current |
| 36800-592 | Topcare Mucus DM | dextromethorphan HBr, guaifenesin | Topco Associates LLC | ANDA | Current |
| 37808-812 | mucus relief dm | dextromethorphan HBr, guaifenesin | H E B | ANDA | Current |
| 41163-599 | equaline mucus dm | dextromethorphan hydrobromide, guaifenesin | Supervalu Inc | ANDA | Current |
| 41163-781 | Equaline Mucus DM | dextromethorphan HBr, guaifenesin | Supervalu Inc | ANDA | Current |
| 41250-436 | mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Meijer Distribution Inc | ANDA | Current |
| 41250-812 | mucus dm | dextromethorphan HBr, guaifenesin | Meijer Distribution Inc | ANDA | Current |
| 46122-637 | good neighbor pharmacy mucus dm | dextromethorphan HBr, guaifenesin | Amerisource Bergen | ANDA | Current |
| 50594-812 | sound body mucus dm | dextromethorphan Hydrobromide, guaifenesin | Big Lots Stores, Inc. | ANDA | Current |
| 55301-812 | Exchange Select Mucus DM | dextromethorphan HBr, guaifenesin | Army & Air Force Exchange Service | ANDA | Current |
| 55910-575 | DG health mucus dm | dextromethorphan HBr, guaifenesin | Dolgencorp, LLC | ANDA | Current |
| 55910-575 | DG health mucus dm | dextromethorphan HBr, guaifenesin | Dolgencorp, LLC | ANDA | Current |
| 55910-575 | DG health mucus dm | dextromethorphan HBr, guaifenesin | Dolgencorp, LLC | ANDA | Current |
| 68391-812 | Berkley and Jensen Mucus Relief DM | dextromethorphan HBr, guaifenesin | BJWC | ANDA | Current |
| 69842-812 | mucus dm extended release | guaifenesin, dextromethorphan HBr | CVS Pharmacy | ANDA | Current |
| 69842-963 | mucus dm extended release | guaifenesin, dextromethorphan hydrobromide | CVS Pharmacy | ANDA | Current |
| 70000-0372 | Leader Mucus DM | dextromethorphan HBr, guaifenesin | Cardinal Health | ANDA | Current |
| 70000-0372 | Leader Mucus DM | dextromethorphan HBr, guaifenesin | Cardinal Health 110, LLC. dba Leader | ANDA | Current |
| 72288-219 | basic care mucus dm | dextromethorphan hydrobromide, guaifenesin | Amazon.com Services LLC | ANDA | Current |
| 72288-812 | basic care mucus dm | dextromethorphan HBr, guaifenesin | Amazon.com Services LLC | ANDA | Current |
| 79903-065 | equate mucus relief dm | dextromethorphan hydrobromide, guaifenesin | Wal-Mart Stores Inc | ANDA | Current |
| 81522-812 | caring mill mucus dm | dextromethorphan HBr, guaifenesin | FSA Store Inc. | ANDA | Current |